Rationale: Environmental exposures have been associated with adverse outcomes in chronic obstructive pulmonary disease (COPD). Approximately one-third of individuals with COPD have allergic sensitization, but it is unknown whether exposure to allergens in the home is associated with outcomes. Objectives: To determine the prevalence and associations of allergen sensitization with exposure to common indoor allergens with symptoms and exacerbation risk in COPD. Methods: Allergen sensitization to five common indoor allergens was assessed in former smokers with COPD. Home settled dust was assessed for presence of corresponding allergens. Sensitization and exposure status was determined and associations evaluated in adjusted models with longitudinal outcomes including symptoms, lung function, and exacerbations. Interactions were assessed between sensitization/exposure status and lung function. Measurements and Main Results: One hundred eighty-three individuals studied were on average 67.3 years of age (SD, 8.22) with average FEV1 of 53.2% (SD, 17.6%). Seventy-seven percent of participants were exposed to at least one tested allergen, and 17% had sensitization with corresponding allergen exposure. After adjustment, sensitization with exposure was associated with lower lung function (β, -8.29; 95% confidence interval [CI], -14.80 to -1.77), higher St. George's Respiratory Questionnaire Total Score (β, 6.71; 95% CI, 0.17 to 13.25), and higher exacerbation risk (odds ratio, 2.31; 95% CI, 1.11 to 4.79). Associations appeared to be more pronounced among individuals with lower lung function. Conclusions: Allergen exposures are common in COPD and associated with adverse outcomes among those with concomitant allergen sensitization. This study establishes allergens as an important home exposure that potentially could be addressed with comprehensive home environmental modification strategies to improve COPD outcomes.
Rationale: Environmental exposures have been associated with adverse outcomes in chronic obstructive pulmonary disease (COPD). Approximately one-third of individuals with COPD have allergic sensitization, but it is unknown whether exposure to allergens in the home is associated with outcomes. Objectives: To determine the prevalence and associations of allergen sensitization with exposure to common indoor allergens with symptoms and exacerbation risk in COPD. Methods: Allergen sensitization to five common indoor allergens was assessed in former smokers with COPD. Home settled dust was assessed for presence of corresponding allergens. Sensitization and exposure status was determined and associations evaluated in adjusted models with longitudinal outcomes including symptoms, lung function, and exacerbations. Interactions were assessed between sensitization/exposure status and lung function. Measurements and Main Results: One hundred eighty-three individuals studied were on average 67.3 years of age (SD, 8.22) with average FEV1 of 53.2% (SD, 17.6%). Seventy-seven percent of participants were exposed to at least one tested allergen, and 17% had sensitization with corresponding allergen exposure. After adjustment, sensitization with exposure was associated with lower lung function (β, -8.29; 95% confidence interval [CI], -14.80 to -1.77), higher St. George's Respiratory Questionnaire Total Score (β, 6.71; 95% CI, 0.17 to 13.25), and higher exacerbation risk (odds ratio, 2.31; 95% CI, 1.11 to 4.79). Associations appeared to be more pronounced among individuals with lower lung function. Conclusions: Allergen exposures are common in COPD and associated with adverse outcomes among those with concomitant allergen sensitization. This study establishes allergens as an important home exposure that potentially could be addressed with comprehensive home environmental modification strategies to improve COPD outcomes.
Authors: D L Rosenstreich; P Eggleston; M Kattan; D Baker; R G Slavin; P Gergen; H Mitchell; K McNiff-Mortimer; H Lynn; D Ownby; F Malveaux Journal: N Engl J Med Date: 1997-05-08 Impact factor: 91.245
Authors: Steven Pascoe; Nicholas Locantore; Mark T Dransfield; Neil C Barnes; Ian D Pavord Journal: Lancet Respir Med Date: 2015-04-12 Impact factor: 30.700
Authors: Torie Grant; Charles Aloe; Matthew Perzanowski; Wanda Phipatanakul; Mary E Bollinger; Rachel Miller; Elizabeth C Matsui Journal: J Allergy Clin Immunol Pract Date: 2016-12-05
Authors: William J Sheehan; Perdita Permaul; Carter R Petty; Brent A Coull; Sachin N Baxi; Jonathan M Gaffin; Peggy S Lai; Diane R Gold; Wanda Phipatanakul Journal: JAMA Pediatr Date: 2017-01-01 Impact factor: 16.193
Authors: Stephanie A Christenson; Katrina Steiling; Maarten van den Berge; Kahkeshan Hijazi; Pieter S Hiemstra; Dirkje S Postma; Marc E Lenburg; Avrum Spira; Prescott G Woodruff Journal: Am J Respir Crit Care Med Date: 2015-04-01 Impact factor: 21.405
Authors: Gerard J Criner; Bartolome R Celli; Christopher E Brightling; Alvar Agusti; Alberto Papi; Dave Singh; Don D Sin; Claus F Vogelmeier; Frank C Sciurba; Mona Bafadhel; Vibeke Backer; Motokazu Kato; Alejandra Ramírez-Venegas; Yu-Feng Wei; Leif Bjermer; Vivian H Shih; Maria Jison; Sean O'Quinn; Natalya Makulova; Paul Newbold; Mitchell Goldman; Ubaldo J Martin Journal: N Engl J Med Date: 2019-05-20 Impact factor: 176.079
Authors: Deepak A Kaji; Andrew J Belli; Meredith C McCormack; Elizabeth C Matsui; D'Ann L Williams; Laura Paulin; Nirupama Putcha; Roger D Peng; Gregory B Diette; Patrick N Breysse; Nadia N Hansel Journal: BMC Pulm Med Date: 2014-09-10 Impact factor: 3.317
Authors: Takudzwa Mkorombindo; John R Balmes; Adnan Custovic; Mark T Dransfield Journal: Am J Respir Crit Care Med Date: 2022-02-15 Impact factor: 21.405